CAS: 934526-89-3 - N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

Formel: C₂₁H₁₆N₆O₂S₂

InChl: InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)

InChI Key: InChIKey=QINPEPAQOBZPOF-UHFFFAOYSA-N

SMILES: O=C(NC1=CC=CC(=C1)S(=O)(=O)NC2=NC=3C=CC=CC3N=C2NC4=CC(OC)=CC=C4Cl)C(N)(C)C

Synonyme:

• 2-Amino-N-[3-[N-[3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide
• 2-Amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide
• 2-Amino-N-[3-[[[3-[(2-chloro-5-methoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-2-methylpropanamide
• 3-Cyano-5-fluorobenzaldehyde
• 3-Fluoro-5-formylbenzonitrile
• Benzonitrile, 3-fluoro-5-formyl-
• N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
• N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
• Pilaralisib
• Propanamide, 2-amino-N-[3-[[[3-[(2-chloro-5-methoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-2-methyl-
• SC
• Sar 245408
• Sar245408
• Xl-147
• Xl147

pilaralisib

CAS: 934526-89-3

• Formel: C₂₅H₂₅ClN₆O₄S
• Reinheit: %
• Farbe und Form: Solid
• Molekulargewicht: 541.0218

Pilaralisib

CAS: 934526-89-3

Pilaralisib (XL-147) is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 …

• Formel: C₂₅H₂₅ClN₆O₄S
• Reinheit: 98.24% - 99.61%
• Farbe und Form: Solid
• Molekulargewicht: 541.02

Pilaralisib

CAS: 934526-89-3

Applications Pilaralisib is a pan-PI3K inhibitor used in the treatment of patients with chronic lymphocytic …

• Formel: C₂₅H₂₅ClN₆O₄S
• Farbe und Form: Neat
• Molekulargewicht: 541.02

XL 147

CAS: 934526-89-3

Inhibits PI3K kinases

• Formel: C₂₅H₂₅ClN₆O₄S
• Reinheit: Min. 95%
• Molekulargewicht: 541.02 g/mol